
MLYS
Mineralys Therapeutics Inc.
$36.90
+$0.85(+2.36%)
48
Overall
50
Value
54
Tech
42
Quality
Market Cap
$2.91B
Volume
2.12M
52W Range
$8.24 - $47.65
Target Price
$49.63
Key Metrics Overview
| Market Cap | $2.91B | P/E Ratio | N/A |
| 52W High | $47.65 | 52W Low | $8.24 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 72.7% |
| Overall Score | 48 | Value Score | 50 |
| Quality Score | 42 | Technical Score | 54 |
Growth Analysis
| EPS Current Est | $-2.65 | EPS Next Est | $-2.8 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MLYS | $36.90 | +2.4% | 2.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mineralys Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW